CVS Health (CVS) is a publicly traded Healthcare sector company. As of May 20, 2026, CVS trades at $93.25 with a market cap of $122.48B and a P/E ratio of 14.37. CVS moved -0.73% today. Year to date, CVS is +17.53%; over the trailing twelve months it is +50.02%. Its 52-week range spans $43.56 to $98.43. Analyst consensus is strong buy with an average price target of $102.35. Rallies surfaces CVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CVS Health Invests $292M in Veteran-Owned Businesses and Expands Military Family Programs: CVS Health invested $292M in veteran-owned small businesses in 2025 and launched new military family programs in North Carolina ahead of planned national expansion. It uses its 9,000 retail pharmacies, 1,000 clinics and 88 million PBM members to deliver tailored healthcare access and economic support for veterans and military families.
| Metric | Value |
|---|---|
| Price | $93.25 |
| Market Cap | $122.48B |
| P/E Ratio | 14.37 |
| EPS | $6.49 |
| Dividend Yield | 0.67% |
| 52-Week High | $98.43 |
| 52-Week Low | $43.56 |
| Volume | 6.00M |
| Avg Volume | 0 |
| Revenue (TTM) | $357.78B |
| Net Income | $8.37B |
| Gross Margin | 39.32% |
17 analysts cover CVS: 0 strong buy, 17 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $102.35.